NAOMI RINGER: Open Payments
NPI 1225510134 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 54 payments from 13 companies in 2025. Trend: 2023 $117 · 2024 $932 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $328 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $259 |
| Madrigal Pharmaceuticals | 7 | $166 |
| Phathom Pharmaceuticals, Inc. | 2 | $133 |
| Janssen Biotech, Inc. | 4 | $83 |
| QOL Medical, LLC | 2 | $78 |
| Lilly USA, LLC | 4 | $77 |
| GENZYME CORPORATION | 3 | $70 |
| Intercept Pharmaceuticals, Inc. | 3 | $49 |
| Celltrion USA Inc. | 2 | $44 |
Products named: ENTYVIO, RINVOQ, REZDIFFRA, VOQUEZNA, DUPIXENT, TREMFYA, SKYRIZI, Sucraid.
Industry payments across FL — which companies pay providers there.
